Cargando…
Immunogenicity and safety of COVID-19 BNT162b2 booster vaccine in end-stage kidney disease patients receiving haemodialysis in Yogyakarta, Indonesia: a cohort prospective study
BACKGROUND: A significant decrease in antibody titres several months after COVID-19 primary vaccination in end-stage kidney disease (ESKD) patients receiving maintenance haemodialysis has recently been reported. The waning in antibody titres has led to the recommendations for a booster dose to incre...
Autores principales: | Puspitasari, Metalia, Sattwika, Prenali D., Hidayat, Auliana R. P., Wijaya, Wynne, Wardhani, Yulia, Intansari, Umi S., Kertia, Nyoman, Purwanto, Bambang, Thobari, Jarir At |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226875/ https://www.ncbi.nlm.nih.gov/pubmed/37248445 http://dx.doi.org/10.1186/s12882-023-03218-x |
Ejemplares similares
-
Immunogenicity and safety of inactivated SARS-CoV-2 vaccine in haemodialysis patients: a prospective cohort study
por: Puspitasari, Metalia, et al.
Publicado: (2023) -
Outcomes of vaccinations against respiratory diseases in patients with end-stage renal disease undergoing hemodialysis: A systematic review and meta-analysis
por: Puspitasari, Metalia, et al.
Publicado: (2023) -
Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis
por: Dekervel, Marine, et al.
Publicado: (2021) -
Cost-Effectiveness Analysis of Two Chemotherapy Regiments FAC vs. Taxane for Operable Breast Cancer Patients in Indonesia
por: Saptaningsih, Agusdini Banun, et al.
Publicado: (2022) -
Persistent Left Superior Vena Cava Identified After Hemodialysis Catheter Insertion: A Case Report
por: Puspitasari, Metalia, et al.
Publicado: (2020)